Literature DB >> 17170103

Liver-selective transgene rescue of hypothalamic-pituitary-adrenal axis dysfunction in 11beta-hydroxysteroid dehydrogenase type 1-deficient mice.

Janice M Paterson1, Megan C Holmes, Christopher J Kenyon, Roderick Carter, John J Mullins, Jonathan R Seckl.   

Abstract

11beta-Hydroxysteroid dehydrogenase type 1 (11beta-HSD1) acts as a reductase in vivo, regenerating active glucocorticoids within cells from circulating inert 11-keto forms, thus amplifying local glucocorticoid action. 11beta-HSD1 is predominantly expressed in liver and also adipose tissue and brain. Mice deficient in 11beta-HSD1 (11beta-HSD1(-/-)) exhibit adrenal hyperplasia, raised basal corticosterone levels, and increased hypothalamic-pituitary-adrenal (HPA) axis responses to stress. Whereas reduced peripheral glucocorticoid regeneration may explain adrenal hypertrophy and exaggerated stress responses, elevated basal glucocorticoid levels support a role for 11beta-HSD1 within the brain in amplifying glucocorticoid feedback. To test this hypothesis, apolipoprotein E-HSD1 mice overexpressing 11beta-HSD1 in liver were intercrossed with 11beta-HSD1(-/-) mice to determine whether complementation of hepatic 11beta-HSD1 can restore adrenal and HPA defects. Transgene-mediated delivery of 11beta-HSD1 activity to the liver rescued adrenal hyperplasia and reversed exaggerated HPA stress responses in 11beta-HSD1(-/-) mice. Unexpectedly, elevated nadir plasma corticosterone levels were also restored to control levels. Consistent with this, CYP11B1 mRNA expression in the adrenal cortex of 11beta-HSD1(-/-) mice was increased by 50% but returned to control levels in 11beta-HSD1(-/-) mice bearing the apolipoprotein E-HSD1 transgene. 11beta-HSD1(-/-) mice have lower plasma glucose levels, but the fall in plasma corticosterone with sucrose supplementation was similar in 11beta-HSD1(-/-) and control mice, suggesting glucose deficiency is not the main mechanism whereby basal corticosterone levels are elevated in the null mice. Thus, regeneration of glucocorticoids by 11beta-HSD1 in the liver normalizes all aspects of HPA axis dysregulation in 11beta-HSD1(-/-) mice, without restoration of enzyme activity in key feedback areas of the forebrain. Therefore, hepatic glucocorticoid metabolism influences basal as well as stress-associated functions of the HPA axis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17170103      PMCID: PMC6443039          DOI: 10.1210/en.2006-0603

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  30 in total

Review 1.  Minireview: 11beta-hydroxysteroid dehydrogenase type 1- a tissue-specific amplifier of glucocorticoid action.

Authors:  J R Seckl; B R Walker
Journal:  Endocrinology       Date:  2001-04       Impact factor: 4.736

Review 2.  11 beta-Hydroxysteroid dehydrogenase.

Authors:  P M Stewart; Z S Krozowski
Journal:  Vitam Horm       Date:  1999       Impact factor: 3.421

3.  Lack of tissue glucocorticoid reactivation in 11beta -hydroxysteroid dehydrogenase type 1 knockout mice ameliorates age-related learning impairments.

Authors:  J L Yau; J Noble; C J Kenyon; C Hibberd; Y Kotelevtsev; J J Mullins; J R Seckl
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

4.  A spoonful of sugar: feedback signals of energy stores and corticosterone regulate responses to chronic stress.

Authors:  Mary F Dallman; Susan F Akana; Kevin D Laugero; Francisca Gomez; Sotara Manalo; M E Bell; Seema Bhatnagar
Journal:  Physiol Behav       Date:  2003-06

5.  Stress and anxious-related behaviors in Lurcher mutant mice.

Authors:  Pascal Hilber; Thomas Lorivel; Catherine Delarue; Jean Caston
Journal:  Brain Res       Date:  2004-04-02       Impact factor: 3.252

6.  Two distal downstream enhancers direct expression of the human apolipoprotein E gene to astrocytes in the brain.

Authors:  S Grehan; E Tse; J M Taylor
Journal:  J Neurosci       Date:  2001-02-01       Impact factor: 6.167

7.  Sucrose ingestion normalizes central expression of corticotropin-releasing-factor messenger ribonucleic acid and energy balance in adrenalectomized rats: a glucocorticoid-metabolic-brain axis?

Authors:  K D Laugero; M E Bell; S Bhatnagar; L Soriano; M F Dallman
Journal:  Endocrinology       Date:  2001-07       Impact factor: 4.736

8.  Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice.

Authors:  N M Morton; M C Holmes; C Fiévet; B Staels; A Tailleux; J J Mullins; J R Seckl
Journal:  J Biol Chem       Date:  2001-08-23       Impact factor: 5.157

9.  Intracellular regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase (11beta-HSD)-1 plays a key role in regulation of the hypothalamic-pituitary-adrenal axis: analysis of 11beta-HSD-1-deficient mice.

Authors:  H J Harris; Y Kotelevtsev; J J Mullins; J R Seckl; M C Holmes
Journal:  Endocrinology       Date:  2001-01       Impact factor: 4.736

10.  Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice.

Authors:  Hiroaki Masuzaki; Hiroshi Yamamoto; Christopher J Kenyon; Joel K Elmquist; Nicholas M Morton; Janice M Paterson; Hiroshi Shinyama; Matthew G F Sharp; Stewart Fleming; John J Mullins; Jonathan R Seckl; Jeffrey S Flier
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

View more
  21 in total

Review 1.  11beta-HSD1, inflammation, metabolic disease and age-related cognitive (dys)function.

Authors:  Karen E Chapman; Jonathan R Seckl
Journal:  Neurochem Res       Date:  2007-10-25       Impact factor: 3.996

2.  11beta-hydroxysteroid dehydrogenase type 1 expression is increased in the aged mouse hippocampus and parietal cortex and causes memory impairments.

Authors:  Megan C Holmes; Roderick N Carter; June Noble; Shruti Chitnis; Amy Dutia; Janice M Paterson; John J Mullins; Jonathan R Seckl; Joyce L W Yau
Journal:  J Neurosci       Date:  2010-05-19       Impact factor: 6.167

3.  Improved heart function follows enhanced inflammatory cell recruitment and angiogenesis in 11betaHSD1-deficient mice post-MI.

Authors:  Sara J McSweeney; Patrick W F Hadoke; Agnieszka M Kozak; Gary R Small; Hiba Khaled; Brian R Walker; Gillian A Gray
Journal:  Cardiovasc Res       Date:  2010-05-21       Impact factor: 10.787

4.  Conditional ablation of mediator subunit MED1 (MED1/PPARBP) gene in mouse liver attenuates glucocorticoid receptor agonist dexamethasone-induced hepatic steatosis.

Authors:  Yuzhi Jia; Navin Viswakarma; Tao Fu; Songtao Yu; M Sambasiva Rao; Jayme Borensztajn; Janardan K Reddy
Journal:  Gene Expr       Date:  2009

5.  Sex dependent influence of a functional polymorphism in steroid 5-α-reductase type 2 (SRD5A2) on post-traumatic stress symptoms.

Authors:  Charles F Gillespie; Lynn M Almli; Alicia K Smith; Bekh Bradley; Kimberly Kerley; Daniel F Crain; Kristina B Mercer; Tamara Weiss; Justine Phifer; Yilang Tang; Joseph F Cubells; Elisabeth B Binder; Karen N Conneely; Kerry J Ressler
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2013-03-15       Impact factor: 3.568

6.  Enduring effects of severe developmental adversity, including nutritional deprivation, on cortisol metabolism in aging Holocaust survivors.

Authors:  Rachel Yehuda; Linda M Bierer; Ruth Andrew; James Schmeidler; Jonathan R Seckl
Journal:  J Psychiatr Res       Date:  2009-01-21       Impact factor: 4.791

7.  11β-hydroxysteroid dehydrogenase type 1, brain atrophy and cognitive decline.

Authors:  Alasdair M J MacLullich; Karen J Ferguson; Louise M Reid; Ian J Deary; John M Starr; Joanna M Wardlaw; Brian R Walker; Ruth Andrew; Jonathan R Seckl
Journal:  Neurobiol Aging       Date:  2010-10-18       Impact factor: 4.673

Review 8.  11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action.

Authors:  Karen Chapman; Megan Holmes; Jonathan Seckl
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

Review 9.  11β-hydroxysteroid dehydrogenases: A growing multi-tasking family.

Authors:  Elise P Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Mol Cell Endocrinol       Date:  2021-02-17       Impact factor: 4.102

10.  Lack of significant metabolic abnormalities in mice with liver-specific disruption of 11β-hydroxysteroid dehydrogenase type 1.

Authors:  Gareth G Lavery; Agnieszka E Zielinska; Laura L Gathercole; Beverly Hughes; Nina Semjonous; Phillip Guest; Khalid Saqib; Mark Sherlock; Gary Reynolds; Stuart A Morgan; Jeremy W Tomlinson; Elizabeth A Walker; Elizabeth H Rabbitt; Paul M Stewart
Journal:  Endocrinology       Date:  2012-05-03       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.